Infliximab ameliorates tumor necrosis factor-alpha-induced insulin resistance by attenuating PTP1B activation in 3T3L1 adipocytes in vitro.

LA, Méndez-García; F, Trejo-Millán; CP, Martínez-Reyes; AN, Manjarrez-Reyna; M, Esquivel-Velázquez; G, Melendez-Mier; S, Islas-Andrade; A, Rojas-Bernabé; J, Kzhyshkowska; G, Escobedo

doi:10.1111/sji.12716

Infliximab ameliorates tumor necrosis factor-alpha-induced insulin resistance by attenuating PTP1B activation in 3T3L1 adipocytes in vitro.

NobleIDNI1P08W73R74S83

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/98AC0AC2.svg?ark=w1%2F20260526%2F98AC0AC2&value=id)](https://nobleid.org/work/w1/20260526/98AC0AC2)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Infliximab ameliorates tumor necrosis factor-alpha-induced insulin resistance by attenuating PTP1B activation in 3T3L1 adipocytes in vitro.

NobleIDNI1P08W73R74S83

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/98AC0AC2.svg?ark=w1%2F20260526%2F98AC0AC2&value=id)](https://nobleid.org/work/w1/20260526/98AC0AC2)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work